FDA Accepts Recros Medica’s Nuvellus Submission
Recros Medica Inc announces that its de novo regulatory submission for the Nuvellus Focal Contouring System has been accepted for review by the US Food and Drug Administration (FDA).
Recros Medica Inc announces that its de novo regulatory submission for the Nuvellus Focal Contouring System has been accepted for review by the US Food and Drug Administration (FDA).